Neuromodulation by a cytokine: Interferon-β differentially augments neocortical neuronal activity and excitability

Journal of Neurophysiology

Volumn 93, Issue 2, 2005, Pages 843-852

  Hadjilambreva, Gergana ^a   Mix, Eilhard ^a   Rolfs, Arndt ^a   Müller, Jana ^a   Strauss, Ulf ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; BETA INTERFERON; BICUCULLINE; CARBACHOL; NICKEL; POTASSIUM ION;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BRAIN FUNCTION; CELLULAR DISTRIBUTION; DOSE RESPONSE; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; EXCITATION; IN VITRO STUDY; INTRACELLULAR RECORDING; MALE; MEMBRANE CURRENT; MULTIPLE SCLEROSIS; NEOCORTEX; NERVE CELL MEMBRANE POTENTIAL; NERVE FIBER MEMBRANE CONDUCTANCE; NEUROMODULATION; NONHUMAN; PERCEPTIVE THRESHOLD; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SOMATOSENSORY CORTEX;

ACTION POTENTIALS; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON-BETA; MALE; NEOCORTEX; NEURONS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR;

EID: 12544256430     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.01224.2003     Document Type: Article

References (54)

1. Adams PR, Brown DA, and Constanti A. Pharmacological inhibition of the M-current. J Physiol 332: 223-262, 1982.
2. + current in mouse neocortical slices. J Neurophysiol 80: 1547-1551, 1998.
3. Barca O, Ferre S, Seoane M, Prieto JM, Lema M, Senaris R, and Arce VM. Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J Neuroimmunol 139: 155-159, 2003.
4. Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, and Hughes TK. The interferons. Mechanisms of action and clinical applications. J Am Med Assoc 266: 1375-1383, 1991.
5. Bartfai T and Schultzberg M. Cytokines in neuronal cell types. Neurochem Int 22: 435-444, 1993.
6. Blalock JE. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann NY Acad Sci 74: 1292-1298, 1994.
7. Bocci V. Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems. Crit Rev Ther Drug Carrier Syst 9: 91-133, 1992.
8. Bramanti P, Sessa E, Rifici C, D'Aleo G, Floridia D, Di Bella P, and Lublin F. Enhanced spasticity in primary progressive MS patients treated with Interferon beta-1b. Neurology 51: 1720-1723, 1998.
9. Calvert MC and Gresser IC. Interferon enhances the excitability of cultured neurons. Nature 278: 558-560, 1979.
10. Connors BW and Gutnick MJ, Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci 13: 99-104, 1990.
11. Coyle PK and Hartung HP. Use of Interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response. Mult Scler 8: 2-9, 2002.
12. Crill WE. Persistent sodium current in mammalian central neurons. Annu Rev Physiol 58: 349-362, 1996.
13. Cudmore RH and Turrigiano GG. Long-term potentiation of intrinsic excitability in LV visual cortical neurons. J Neurophysiol 92: 341-348, 2004.
14. Dafny N, Prieto-Gomez B, Bong WQ, and Reyes-Vazquez C. Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex. Brain Res 734: 269-274, 1996.
15. Dafny N, Prieto-Gomez B, Dong WQ, and Reyes-Vazquez C. Effects of interferon on the central nervous system. In: Interferon Therapy of Multiple Sclerosis, edited by Reder AT. New York: Dekker; 1997, p. 115-137.
16. D'Arcangelo G, Grassi F, Ragozzino D, Santoni A, Tancredi V, and Eusebi F. Interferon inhibits synaptic potentiation in rat hippocampus. Brain Res 564: 245-248, 1991.
17. Durelli L, Oggero A, Verdun E, Barbero P, Pipieri A, Isoardo G, Ricci A, Clerico M, Bradac G, Bergamasco B, and Bergui M. Interferon-beta dose and efficacy: the OPTIMS study. Neurol Sci 1: 201-203, 2001.
18. Fabry Z, Raine CS, and Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 15: 218-224, 1994.
19. Gerschlager W, Beisteiner R, Deecke L, Dirnberger G, Endl W, Kollegger H, Lindinger G, Vass K, and Lang W. Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: a 1-year follow-up. Eur Neurol 44: 205-209, 2000.
20. Goldman MS, Golowasch J, Marder E, and Abbott LF. Global structure, robustness, and modulation of neuronal models. J Neurosci 21: 5229-5238, 2001.
21. Hallal DE, Farias AS, Oliveira EC, Diaz-Bardales BM, Brandao CO, Protti GG, Pereira FG, Metze IL, and Santos LM. Costimulatory molecule expression on leukocytes from mice with experimental autoimmune encephalomyelitis treated with IFN-β. J Interferon Cytokine Res 23: 293-298, 2003.
22. Harris NC and Constanti A. Mechanism of block by ZD 7288 of the hyperpolarization-activated inward rectifying current in guinea pig substantia nigra neurons in vitro. J Neurophysiol 74: 2366-2378, 1995.
23. Hamm m S, Rudel R, and Brinkmeier H. Excitatory sodium currents of NH15-CA2 neuroblastoma x glioma hybrid cells are differently affected by interleukin-2 and interleukin-1β. Pfluegers 433: 160-165, 1996.
24. Hopkins SJ and Rothwell NJ. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 18: 83-88, 1995.
25. Hu S, Sheng WS, Ehrlich LC, Peterson PK, and Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7: 153-159, 2000.
26. Jahromi SS, Wentlandt K, Piran S, and Carlen PL. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J Neurophysiol 88: 1893-1902, 2002.
27. Jiang CL and Lu CL. Interleukin-2 and its effects in the central nervous system. Biol Signals Recept 7: 148-156, 1998.
28. Katafuchi T, Take S, and Hori T. Roles of cytokines in the neural-immune interactions: modulation of NMDA responses by IFN-alpha. Neurobiology 3: 319-227, 1995.
29. Khawaled R, Bruening-Wright A, Adelman JP, and Maylie J. Bicuculline block of small-conductance calcium-activated potassium channels. Pfluegers 438: 314-321, 1999.
30. Kiehn O and Harris-Warrick RM. 5-HT modulation of hyperpolarization- activated inward current and calcium-dependent outward current in a crustacean motor neuron. J Neurophysiol 68: 496-508, 1992.
31. Kim MO, Si Q, Zhou JN, Pestell RG, Brosnan CF, Locker J, and Lee SC. Interferon-beta activates multiple signaling cascades in primary human microglia. J Neurochem 81: 1361-1371, 2002.
32. Kinnunen E, Timonen T, Pirttila T, Kalliomaki P, Ketonen L, Matikainen E, Sepponen R, and Juntunen J. Effects of recombinant alpha-2b-interferon therapy in patients with progressive MS. Acta Neurol Scand 87: 457-460, 1993.
33. Kloppenburg P, Levini RM, and Harris-Warrick RM. Dopamine modulates two potassium currents and inhibits the intrinsic firing properties of an identified motor neuron in a central pattern generator network. J Neurophysiol 81: 29-38, 1999.
34. Köller H, Siebler M, and Hartung HP. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog Neurobiol 52: 1-26, 1997.
35. Mendoza-Fernandez V, Andrew RD, and Barajas-Lopez C. Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res 885: 14-24, 2000.
36. Müller M, Fontana A, Zbinden G, and Gahwiler BH. Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 619: 157-162, 1993.
37. Nakashima T, Hori T, Kuriyama K, and Matsuda T. Effects of interferon-alpha on the activity of preoptic thermosensitive neurons in tissue slices. Brain Res 454: 361-367, 1988.
38. Qiao H, Sakamoto T, Hinton DR, Gopalakrishna R, Ishibashi T, Ryan SJ, and Inomata H. Interferon beta affects retinal pigment epithelial cell proliferation via protein kinase C pathways. Ophthalmologica 215: 401-407, 2001.
39. Ransohoff RM. Cellular responses to interferons and other cytokines: the Jak -STAT paradigm. N Engl J Med 338: 616-618, 1998.
40. Reyes-Vazquez C, Mendoza-Fernandez V, Herrera-Ruiz M, and Dafny N. Interferon modulates glucose-sensitive neurons in the hypothalamus. Exp Brain Res 116: 519-524, 1997.
41. A receptor-mediated inhibition in adult rat somatosensory cortex. J Neurophysiol 75: 1589-1600, 1996.
42. Schlichter LC. Acute exposure to human IFN-a affects ion currents in human natural killer cells. Can J Physiol Pharmac 70: 365-376, 1992.
43. Shibata M and Blatteis CM. Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices. Am J Physiol Regulatory Integrative Comp Physiol 261: R1096-R1103, 1991.
44. Smith RA, Norris F, Palmer D, Bernhardt L, and Wills RJ. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration. Clin Pharmacol Ther 37: 85-88, 1985.
45. Spruston N and Johnston D. Perforated patch-clamp analysis of the passive membrane properties of three classes of hippocampal neurons. J Neurophysiol 67: 508-529, 1992.
46. Spruston N, Schiller Y, Stuart GJ, and Sakmann B. Activity-dependent action potential invasion into CA1 pyramidal neuron dendrites. Science 268: 297-300, 1995.
47. Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest 100: 2641-2647, 1997.
48. h is associated with enhanced excitability and absence epilepsy. Eur J Neurosci 19: 3048-58, 2004.
49. Szelényi J. Cytokines and the central nervous system. Brain Res Bull 54: 329-338, 2001.
50. Taniguchi T and Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14: 111-116, 2002.
51. Teige I, Treschow A, Teige A, Mattson R, Navikas V, Leanderson T, Holmdahl R, and Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 170: 4776-4784, 2003.
52. Ulrich D. Differential arithmetic of shunting inhibition for voltage and spike rate in neocortical pyramidal cells. Eur J Neurosci 18: 2159-2165, 2003.
53. Villarroya H, Marie Y, Ouallet JC, Le Saux F, Tchelingerian JL, and Baumann N. Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction. J Neurosci Res 49: 592-599, 1997.
54. Walther EU and Hohlfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 53: 1622-1627, 1999.